Bio Farma to Develop Hemophilia Medicine

By Editorial Team 07/10/2022
blood sample test
Summary

PT Bio Farma has partnered with a British pharmaceutical company, ProFactor Pharma, to develop the blood product Recombinant Factor VIII. Bio Farma President Director Honesti Basyir said the company would get the exclusive right to co-develop the blood product Recombinant Factor VIII globally.

Bio Farma will also act as the exclusive producer for the global supply of Recombinant Factor VIII products in ASEAN and India. Beyond these territories, sales and marketing will be carried out by partner companies appointed by ProFactor Pharma.

Honesti said that the collaboration would further maximize Bio Farma's innovation and performance, especially related to its mission to produce international quality and affordable life sciences products. "Technology transfer cooperation starts from the upstream to downstream processes," Honesti said on Wednesday.

Register now and get free access.

If you want to get free access to our Daily Insights and Weekly Digest, please click "Sign up" button below. If you already have an account, please login.

Sign up
Log in
What do subscribers receive?

As a subscriber, you'll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Register now and get free access, click here to register. Feel free to contact us with any additional questions you have.